Hepatitis C Virus Program

The recommended treatment for Hepatitis C Virus (HCV) is Mavyret, which can be dispensed in an eight-week supply. Providers who have prescriptive authority can prescribe Mavyret to their patients with a positive HCV diagnosis. Prior authorization is not required for Medicaid.

The Centers for Disease Control and Prevention recommends
patients testing anti-HCV positive/reactive should have follow-up testing with an FDA-approved nucleic acid test (NAT) for detection of HCV RNA.

Mavyret has a Nurse Ambassador Program available for additional support. Please have your patients call 1-877- MAVYRET to enroll once the treatment has been prescribed.